查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1821621

2025年全球细胞增殖市场报告

Cell Expansion Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年细胞增殖市场规模将快速成长，到2029年将达到593.1亿美元，复合年增长率为16.4%。预测期内的成长归因于生物技术投资的增加、干细胞研究、临床试验和药物开发的扩展、个人化医疗的需求以及生物生物银行和细胞库的建立。预测期内的主要趋势包括技术进步、产品创新和策略联盟。

未来五年16.4%的成长率预测比我们先前的预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。贸易摩擦可能导致新加坡和日本开发的自动化细胞培养系统和GMP级开发培养基价格上涨，阻碍美国再生医学的发展，造成生产瓶颈，导致临床试验延迟三至六个月。由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易的负面影响，贸易摩擦的影响可能更为广泛。

慢性病盛行率的上升预计将在未来推动细胞增殖市场的需求。慢性病是一种长期疾病，有时可以控製或管理，但通常无法治癒。其盛行率的上升是由于吸烟、营养不良、缺乏运动和过量饮酒等因素造成的。细胞增殖在补充营养和防止可能影响文化表现的有毒代谢废物累积方面发挥关键作用。例如，美国国家医学图书馆下属的国家生物技术资讯中心 (NCBI) 在 2023 年 1 月预测，到 2050 年，患有至少一种慢性病的 50 岁及以上人群的数量将增加 99.5%，从 2020 年的 7,152.2 万人增加到 1.4266 亿人。因此，慢性病盛行率的上升预计将推动细胞增殖市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球细胞生长：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球细胞增生市场：成长率分析
  • 全球细胞增殖市场表现：规模与成长，2019-2024
  • 全球细胞增殖市场预测：规模与成长，2024-2029年，2034年
  • 全球细胞增生：总目标市场（TAM）

第六章 市场细分

  • 全球细胞扩增市场：按细胞类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 哺乳动物
  • 微生物
  • 其他细胞类型
  • 全球细胞增殖市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 耗材
  • 试剂
  • 培养基
  • 血清
  • 一次性的
  • 装置
  • 全球细胞增殖市场：依应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 生物製药
  • 组织培养与工程
  • 疫苗生产
  • 药物开发
  • 基因治疗
  • 癌症研究
  • 干细胞研究
  • 其他用途
  • 全球细胞扩增市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 生物製药和生物技术公司
  • 研究所
  • 细胞库
  • 其他最终用户
  • 全球细胞增殖市场：按哺乳动物、类型、表现和预测的细分，2019-2024 年、2024-2029 年、2034 年
  • 贴壁细胞
  • 悬浮细胞
  • 干细胞
  • 全球细胞扩增市场：按微生物、类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 细菌细胞
  • 酵母菌细胞
  • 真菌细胞
  • 全球细胞增殖市场：其他细胞类型细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 植物细胞
  • 昆虫细胞
  • 融合瘤

第七章 区域和国家分析

  • 全球细胞增殖市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球细胞增殖市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 细胞增殖市场：竞争格局
  • 细胞增殖市场：公司简介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group Overview, Products and Services, Strategy and Financial Analysis
    • Corning Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Sartorius Stedim Biotech SA
  • Terumo Corporation
  • Miltenyi Biotec GmbH
  • Danaher Corporation
  • Stemcell Technologies Inc.
  • Beckman Coulter Inc.
  • Takara Bio Inc.
  • RepliCel Life Sciences
  • Neximmune Inc.
  • Celltainer Biotech BV
  • GE HealthCare Technologies Inc.
  • ReproCELL USA Inc.
  • iXCells Biotechnologies Inc.
  • Neuromics LLC
  • G&G Technologies Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年细胞增生市场：提供新机会的国家
  • 2029 年细胞增殖市场：细分领域带来新机会
  • 2029年细胞增殖市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r22455u

Cell expansion is a cellular process employed to generate new cell wall material, with the primary objective of regulating the flexibility of the wall and facilitating its stretching and expansion in a specific area. Essential to this process are cell-wall-associated proteins belonging to the expansion family.

The main categories of cell expansion include mammalian, microbial, and other types. Mammalian cell expansion involves the cultivation of cells derived from mammals, conducted through the in vitro cultivation of cells in flasks or bioreactors. The products associated with mammalian cell expansion encompass consumables, reagents, media, serums, disposables, and instruments. These products find application in various fields such as biopharmaceuticals, tissue culture and engineering, vaccine production, drug development, gene therapy, cancer research, stem cell research, and others. The end-users of mammalian cell expansion products include biopharmaceutical and biotechnology companies, research institutes, cell banks, and other relevant entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The cell expansion market research report is one of a series of new reports from The Business Research Company that provides cell expansion market statistics, including cell expansion industry global market size, regional shares, competitors with a cell expansion market share, detailed cell expansion market segments, market trends and opportunities, and any further data you may need to thrive in the cell expansion industry. This cell expansion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell expansion market size has grown rapidly in recent years. It will grow from $28.11 billion in 2024 to $32.31 billion in 2025 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to public awareness and acceptance, cell-based research applications, rising demand for cell-based therapies, biopharmaceutical industry growth, regenerative medicine advancements.

The cell expansion market size is expected to see rapid growth in the next few years. It will grow to $59.31 billion in 2029 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to rising investments in biotechnology, expanding stem cell research, clinical trials and drug development, demand for personalized medicine, biobanking and cell repositories. Major trends in the forecast period include technological advancements, product innovations, strategic collaborations.

The forecast of 16.4% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. regenerative medicine by inflating prices of automated cell culture systems and GMP-grade expansion media developed in Singapore and Japan, resulting in production bottlenecks that delay clinical trials by 3-6 months. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic diseases is anticipated to drive the demand for the cell expansion market in the future. Chronic diseases are long-lasting conditions that often cannot be cured, although they can sometimes be managed or controlled. Their increasing prevalence is attributed to factors such as tobacco use, poor nutrition, physical inactivity, and excessive alcohol consumption. Cell expansion plays a crucial role in replenishing nutrients and preventing the buildup of toxic metabolic waste products that could hinder culture performance. For instance, in January 2023, the National Center for Biotechnology Information (NCBI), part of the US National Library of Medicine, projected that by 2050, the number of individuals aged 50 and older with at least one chronic illness will rise by 99.5%, increasing from 71.522 million in 2020 to 142.66 million. Consequently, the growing incidence of chronic diseases is expected to boost the growth of the cell expansion market.

The growth of the cell expansion market is expected to be propelled by increasing government funding for research and development. Government funding plays a crucial role in fostering innovation, advancing cell-based therapies, and accelerating progress in regenerative medicine. An illustrative example is the National Cancer Institute, a US-based government agency, which received a budget of $7.3 billion in fiscal year 2023 from the United States Congress, marking a $408 million increase from 2022. This substantial increase in government funding for research and development is a driving force behind the growth of the cell expansion market.

Leading companies in the cell expansion market are focusing on advancements in bioprocessing technologies, such as automated 3D bioreactor systems, to improve the efficiency and scalability of cell production for therapeutic purposes. PluriCDMO specializes in large-scale, automated manufacturing of cell therapies utilizing a proprietary 3D bioreactor system, ensuring consistent, high-quality production from early development to clinical trials. For example, in January 2024, Pluristem Therapeutics Inc., a biotechnology company based in Israel, launched a new division called PluriCDMO that will provide cell therapy manufacturing services as a contract development and manufacturing organization (CDMO). This new division features a 47,000-square-foot good manufacturing practice (GMP) facility dedicated to cell therapy production. Through PluriCDMO, the company will offer services ranging from early preclinical development to late-stage clinical trials and commercialization.

Major companies in the cell expansion market are intensifying their focus on introducing advanced bioprocessing platforms, such as the Quantum Flex Cell Expansion System, to gain a competitive edge. The Quantum Flex Cell Expansion System, launched by Terumo Blood and Cell Technologies in June 2023, is designed for scalable and flexible expansion of cell therapies, providing efficient and controlled manufacturing capabilities for cell-based medical treatments. This system supports the expansion of various applications, including suspension and adherent cells, viral vectors, and exosome production, offering the necessary flexibility, scalability, and connectivity to support the growth of cell therapies.

In a strategic move, Sartorius AG, a Germany-based pharmaceutical company, acquired Polyplus-Transfection SA for $2.36 billion in March 2023. This acquisition positions Sartorius AG to strengthen its supply of cell and gene therapy solutions, expanding its portfolio for gene therapies and gene-modified cell therapies. Polyplus-Transfection SA, based in France, is a biotechnology company supporting gene and cell therapy, biologics manufacturing, and life science research.

Major companies operating in the cell expansion market are Thermo Fisher Scientific Inc., Becton Dickinson and Company, Lonza Group, Corning Inc., Merck KGaA, Sartorius Stedim Biotech SA, Terumo Corporation, Miltenyi Biotec GmbH, Danaher Corporation, Stemcell Technologies Inc., Beckman Coulter Inc., Takara Bio Inc., RepliCel Life Sciences, Neximmune Inc., Celltainer Biotech BV, GE HealthCare Technologies Inc., ReproCELL USA Inc., iXCells Biotechnologies Inc., Neuromics LLC, G&G Technologies Inc., Eppendorf AG, Avantor Inc., Bio-Techne Corporation, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., Lifeline Scientific Inc., Princeton Cryotech Inc., VWR International LLC, Azenta US Inc., MVE Biological Solutions LLC, BioCision LLC, BioSpherix Ltd., Worthington Industries Inc.

North America was the largest region in the cell expansion market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell expansion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell expansion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell expansion market includes revenues earned by entities by providing bioreactors and automated cell expansion systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Expansion Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell expansion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell expansion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell expansion market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Cell Type: Mammalian; Microbial; Other Cell Types
  • 2) By Product: Consumables; Reagents; Media; Serum; Disposables; Instruments
  • 3) By Application: Biopharmaceuticals; Tissue Culture And Engineering; Vaccine Production; Drug Development; Gene Therapy; Cancer Research; Stem Cell Research; Other Applications
  • 4) By End-user: Biopharmaceutical And Biotechnology Companies; Research Institutes; Cell Banks; Other End-Users
  • Subsegments:
  • 1) By Mammalian: Adherent Cells; Suspension Cells; Stem Cells
  • 2) By Microbial: Bacterial Cells; Yeast Cells; Fungal Cells
  • 3) By Other Cell Types: Plant Cells; Insect Cells; Hybridoma Cells
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Becton Dickinson and Company; Lonza Group; Corning Inc.; Merck KGaA; Sartorius Stedim Biotech SA; Terumo Corporation; Miltenyi Biotec GmbH; Danaher Corporation; Stemcell Technologies Inc.; Beckman Coulter Inc.; Takara Bio Inc.; RepliCel Life Sciences; Neximmune Inc.; Celltainer Biotech BV; GE HealthCare Technologies Inc.; ReproCELL USA Inc.; iXCells Biotechnologies Inc.; Neuromics LLC; G&G Technologies Inc.; Eppendorf AG; Avantor Inc.; Bio-Techne Corporation; BioLife Solutions Inc.; Cesca Therapeutics Inc.; Core Dynamics Ltd.; Lifeline Scientific Inc.; Princeton Cryotech Inc.; VWR International LLC; Azenta US Inc.; MVE Biological Solutions LLC; BioCision LLC; BioSpherix Ltd.; Worthington Industries Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell Expansion Market Characteristics

3. Cell Expansion Market Trends And Strategies

4. Cell Expansion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cell Expansion Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cell Expansion PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cell Expansion Market Growth Rate Analysis
  • 5.4. Global Cell Expansion Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cell Expansion Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cell Expansion Total Addressable Market (TAM)

6. Cell Expansion Market Segmentation

  • 6.1. Global Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mammalian
  • Microbial
  • Other Cell Types
  • 6.2. Global Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consumables
  • Reagents
  • Media
  • Serum
  • Disposables
  • Instruments
  • 6.3. Global Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharmaceuticals
  • Tissue Culture And Engineering
  • Vaccine Production
  • Drug Development
  • Gene Therapy
  • Cancer Research
  • Stem Cell Research
  • Other Applications
  • 6.4. Global Cell Expansion Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharmaceutical And Biotechnology Companies
  • Research Institutes
  • Cell Banks
  • Other End-Users
  • 6.5. Global Cell Expansion Market, Sub-Segmentation Of Mammalian, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adherent Cells
  • Suspension Cells
  • Stem Cells
  • 6.6. Global Cell Expansion Market, Sub-Segmentation Of Microbial, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacterial Cells
  • Yeast Cells
  • Fungal Cells
  • 6.7. Global Cell Expansion Market, Sub-Segmentation Of Other Cell Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plant Cells
  • Insect Cells
  • Hybridoma Cells

7. Cell Expansion Market Regional And Country Analysis

  • 7.1. Global Cell Expansion Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cell Expansion Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell Expansion Market

  • 8.1. Asia-Pacific Cell Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell Expansion Market

  • 9.1. China Cell Expansion Market Overview
  • 9.2. China Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell Expansion Market

  • 10.1. India Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell Expansion Market

  • 11.1. Japan Cell Expansion Market Overview
  • 11.2. Japan Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell Expansion Market

  • 12.1. Australia Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell Expansion Market

  • 13.1. Indonesia Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell Expansion Market

  • 14.1. South Korea Cell Expansion Market Overview
  • 14.2. South Korea Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell Expansion Market

  • 15.1. Western Europe Cell Expansion Market Overview
  • 15.2. Western Europe Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell Expansion Market

  • 16.1. UK Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell Expansion Market

  • 17.1. Germany Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell Expansion Market

  • 18.1. France Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell Expansion Market

  • 19.1. Italy Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell Expansion Market

  • 20.1. Spain Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell Expansion Market

  • 21.1. Eastern Europe Cell Expansion Market Overview
  • 21.2. Eastern Europe Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell Expansion Market

  • 22.1. Russia Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell Expansion Market

  • 23.1. North America Cell Expansion Market Overview
  • 23.2. North America Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell Expansion Market

  • 24.1. USA Cell Expansion Market Overview
  • 24.2. USA Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell Expansion Market

  • 25.1. Canada Cell Expansion Market Overview
  • 25.2. Canada Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell Expansion Market

  • 26.1. South America Cell Expansion Market Overview
  • 26.2. South America Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell Expansion Market

  • 27.1. Brazil Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell Expansion Market

  • 28.1. Middle East Cell Expansion Market Overview
  • 28.2. Middle East Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell Expansion Market

  • 29.1. Africa Cell Expansion Market Overview
  • 29.2. Africa Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell Expansion Market Competitive Landscape And Company Profiles

  • 30.1. Cell Expansion Market Competitive Landscape
  • 30.2. Cell Expansion Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Lonza Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Corning Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Cell Expansion Market Other Major And Innovative Companies

  • 31.1. Sartorius Stedim Biotech SA
  • 31.2. Terumo Corporation
  • 31.3. Miltenyi Biotec GmbH
  • 31.4. Danaher Corporation
  • 31.5. Stemcell Technologies Inc.
  • 31.6. Beckman Coulter Inc.
  • 31.7. Takara Bio Inc.
  • 31.8. RepliCel Life Sciences
  • 31.9. Neximmune Inc.
  • 31.10. Celltainer Biotech BV
  • 31.11. GE HealthCare Technologies Inc.
  • 31.12. ReproCELL USA Inc.
  • 31.13. iXCells Biotechnologies Inc.
  • 31.14. Neuromics LLC
  • 31.15. G&G Technologies Inc.

32. Global Cell Expansion Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Expansion Market

34. Recent Developments In The Cell Expansion Market

35. Cell Expansion Market High Potential Countries, Segments and Strategies

  • 35.1 Cell Expansion Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cell Expansion Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cell Expansion Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer